{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T04:34:00.189811",
  "document": "Chromosome-10-Monosomy-10p.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Chromosome-10-Monosomy-10p.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 2,
  "total_validated": 2,
  "total_rejected": 0,
  "total_investigational": 0,
  "drugs": [
    {
      "matched_text": "parathyroid hormone",
      "preferred_name": "parathyroid hormone",
      "brand_name": "NATPARA",
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": "Parathyroid Hormone",
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": "INJECTABLE",
      "route": "INJECTION",
      "marketing_status": "Prescription",
      "codes": {
        "rxcui": null,
        "mesh": "D010281",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "FDA_NDA",
          "code": "BLA125511",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D010281",
          "display": "Parathyroid Hormone"
        }
      ],
      "context": " by underdevelopment or absence of the thymus and parathyroid glands, potentially causing abnormalities of the immune system, deficient production of parathyroid hormone (hypoparathyroidism), a heart defect, and associated findings. In many cases, chromosome 10, monosomy 10p appears to occur spontaneously (de novo) fo",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_fda_approved_drugs.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Teriparatide",
        "parathyroid hormone (1-34) bovine",
        "parathyroid hormone (3-34)"
      ],
      "pubtator_normalized_name": "Parathyroid Hormone",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "thymus",
      "preferred_name": "THYMUS",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "C000713830",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "10562",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C000713830",
          "display": "thyme oil"
        }
      ],
      "context": " affected individuals have some features of DiGeorge syndrome (DGS). DGS is a congenital disorder characterized by underdevelopment or absence of the thymus and parathyroid glands, potentially causing abnormalities of the immune system, deficient production of parathyroid hormone (hypoparathyroidism), a h",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "thyme oil",
      "enrichment_source": "pubtator3"
    }
  ]
}